We previously found that high ZNF217 expression is a prognostic indicator in general as well as in ER+HER2+LN− patients with breast cancer correlating with shorter overall, disease-specific, and relapse-free survival [3]. The gene discussed is ERBB2; the disease is breast carcinoma.